Table 3.
Compound | R1 | H Plasma Stability (half-life min)a | Kinetic solubility (µM)b | CHI logDc | H Skin S9 (half-life min)d | S1PR1 pIC50e |
---|---|---|---|---|---|---|
11 | OH | >180 | – | – | – | <6 (0) |
12d | 180 | 117 | 3.0 | 152 | – | |
12e | 61 | 79 | 2.8 | 40 | – | |
12f | 9 | 79 | 3.3 | 23 | <6 (0) |
Incubated in human plasma at 37 °C.
The aqueous solubility of the test compounds was measured using laser nephelometry.
Reverse-phase HPLC method to determine the chromatographic hydrophobicity index (CHI).
Stability measured in skin S9 over 180 mins in the presence of enzymatic cofactors.
All pIC50s reported in this table correspond to n of 2, reported as their geometric mean. The range of pIC50 values is provided in brackets.